Rachel King - Nov 12, 2024 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Director
Signature
/s/ Alan Musso as attorney-in-fact for Rachel King
Stock symbol
FULC
Transactions as of
Nov 12, 2024
Transactions value $
$0
Form type
4
Date filed
11/14/2024, 04:15 PM
Previous filing
Jun 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +60K $0.00 60K Nov 12, 2024 Common Stock 60K $3.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on November 12, 2024 and is scheduled to vest in equal monthly installments until November 12, 2027, subject to continued service.